Application 091616
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LITHIUM CARBONATE | LITHIUM CARBONATE | TABLET, EXTENDED RELEASE;ORAL | 450MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091616-001 | LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2011-02-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091616-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091616-001 | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2011-02-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091616-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lithium Carbonate ER | LITHIUM CARBONATE | Coupler LLC | 51b503f5-211f-a9cc-e063-6294a90a9895 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 091616 ANDA091616 |
| Lithium Carbonate ER | LITHIUM CARBONATE | REMEDYREPACK INC. | bd4b07d3-ce42-440f-aec3-19f4d1c445a9 | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 091616 ANDA091616 |
| Lithium Carbonate ER | LITHIUM CARBONATE | Glenmark Pharmaceuticals Inc., USA | 525a9d9b-cbb1-4644-a28a-8bba96f09348 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 091616 ANDA091616 68462-224 |
| Lithium Carbonate ER | LITHIUM CARBONATE | AvKARE | d8ddff4d-2b77-a8f2-e053-2a95a90a5fc0 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 091616 ANDA091616 42291-496 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42291-496 | Lithium Carbonate | Lithium Carbonate | AvKARE | ANDA | Current |
| 63629-7903 | Lithium Carbonate | Lithium Carbonate | Bryant Ranch Prepack | ANDA | Current |
| 63629-7903 | Lithium Carbonate | Lithium Carbonate | Bryant Ranch Prepack | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |